+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
CorMedix Inc - logo

CorMedix is a commercial-stage pharmaceutical company focused on the treatment of infectious, inflammatory, and other serious diseases. The company markets Neutrolin, a catheter lock solution for the prevention of catheter related bloodstream infections. Neutrolin is approved as a CE Marked medical device in Europe where it was shown to reduce catheter-related bloodstream infections by 96% and thrombosis by 96.7%. Founded in 2006, it is based in Bridgewater, New Jersey.

Osteosarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Osteosarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • April 2022
  • 316 Pages
  • Global
From
Neuroblastoma - Pipeline Review, H2 2020 - Product Thumbnail Image

Neuroblastoma - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 1084 Pages
  • Global
From
Neuroblastoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Neuroblastoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 308 Pages
  • Global
From
Osteosarcoma - Pipeline Review, H2 2020 - Product Thumbnail Image

Osteosarcoma - Pipeline Review, H2 2020

  • Drug Pipelines
  • August 2020
  • 868 Pages
  • Global
From
Surgical Wound Infections - Pipeline Insight, 2024 - Product Thumbnail Image

Surgical Wound Infections - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Cormedix Inc. (CRMD:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry - Product Thumbnail Image

Cormedix Inc. (CRMD:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry

  • Company Profile
  • May 2023
  • 89 Pages
From
CorMedix, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis - Product Thumbnail Image

CorMedix, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

  • Company Profile
  • April 2024
  • 50 Pages
From
Comprehensive Report on CorMedix Inc, including SWOT, PESTLE and Business Model Canvas - Product Thumbnail Image

Comprehensive Report on CorMedix Inc, including SWOT, PESTLE and Business Model Canvas

  • SWOT Analysis
  • August 2023
  • 90 Pages
From
  • 8 Results (Page 1 of 1)
Loading Indicator